리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 07월
페이지 정보:영문 381 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 정맥내(IV) 수액 치료 시장은 2030년까지 39억 달러에 도달
2024년에 26억 달러로 추정되는 정맥내(IV) 수액 치료 세계 시장은 2024-2030년간 CAGR 6.7%로 성장하여 2030년에는 39억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 면역력 증강제는 CAGR 8.4%를 나타내고, 분석 기간 종료시에는 16억 달러에 이를 것으로 예측됩니다. 에너지 부스터 분야의 성장률은 분석 기간중 CAGR 4.5%로 추정됩니다.
미국 시장은 7억 1,490만 달러로 추정, 중국은 CAGR 10.8%로 성장 예측
미국의 정맥내(IV) 수액 치료 시장은 2024년에 7억 1,490만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2024-2030년간 CAGR 10.8%로 성장을 지속하여, 2030년에는 8억 1,710만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.2%와 6.6%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 4.4%를 나타낼 전망입니다.
세계의 정맥내(IV) 수액 치료 시장 - 주요 동향과 촉진요인 정리
수액 치료이 헬스케어 및 웰니스 산업에서 인기를 끌고 있는 이유
정맥 내(IV) 수액 치료 시장은 급속한 수분 보충, 웰빙 최적화, 정맥 영양 주입이 필요한 치료에 대한 소비자의 인식이 높아지면서 큰 성장세를 보이고 있습니다. 정맥 내 수분 보충 요법은 임상 환경, 스포츠 회복, 미용 의료, 웰니스 센터 등에서 사용되며, 필수 수분, 전해질, 비타민, 약물을 혈류에 직접 공급하여 즉각적으로 흡수되어 효과를 발휘합니다.
초기에는 병원이나 응급실에서 중증 탈수, 영양실조, 만성질환에 사용되었으나, 현재는 웰니스 클리닉, 스파, 이동식 링거 서비스로 확대되어 숙취 해소, 면역력 강화, 노화 방지, 운동 능력 회복, 건강 전반을 추구하는 소비자들을 대상으로 하고 있습니다. 바이오해킹 문화의 부상, 유명인의 추천, 소셜 미디어를 통한 홍보가 개인의 건강 목표에 맞춘 맞춤형 링거에 대한 수요에 박차를 가하고 있습니다.
수액 제제, 휴대용 주입 장치, 주문형 수분 공급 서비스의 발전으로 인해 수액 치료 시장은 특히 소비자들이 예방적 건강 관리, 개인 맞춤형 웰니스 솔루션, 피로, 시차, 편두통, 면역력 강화를 위한 비침습적 치료법을 선호함에 따라 지속적으로 성장할 것으로 예측됩니다. 계속 확대될 것으로 예측됩니다.
정맥 내 수액 치료 시장을 이끄는 주요 동향은 무엇인가?
정맥주사 치료의 가장 큰 트렌드 중 하나는 이동식 및 재택 수액 서비스의 확대입니다. 소비자들은 면허를 소지한 전문가가 집에서 편리하게 수액치료를 받을 수 있는 홈케어 서비스를 원하고 있으며, 병원 진료를 피하고 편안한 환경에서 수액치료를 받을 수 있도록 하고 있습니다. 이러한 추세는 특히 도심이나 기업의 웰니스 프로그램, 컨시어지 의료 서비스에서 두드러지게 나타나고 있습니다.
또 다른 큰 흐름은 개인 맞춤형 투약 제제의 등장입니다. 클리닉에서는 획일적인 수분 보충 요법이 아닌, 특정 요구에 맞는 비타민, 미네랄, 항산화제, 아미노산, 약물을 포함한 맞춤형 수액 주사를 제공합니다. AI를 활용한 건강 평가와 디지털 헬스 플랫폼의 통합도 시장을 형성하는 추세입니다. 수액 클리닉과 모바일 제공업체는 AI 기반 진단, 원격 건강 상담, 웨어러블 기술을 활용하여 수분 보충 수준, 비타민 결핍, 대사 건강 상태를 분석하여 환자가 최적의 수액 치료을 받을 수 있도록 돕고 있습니다.
피트니스 및 스포츠 회복을 위한 정맥주사 요법의 확대도 수요를 촉진하고 있습니다. 많은 운동선수, 헬스장, 주말 운동선수들은 근육 회복, 지구력, 운동 후 수분 보충을 돕기 위해 아미노산, 전해질, 성능 향상 영양소를 주입한 수액 주입을 통해 수분을 보충하는 것에 주목하고 있습니다. 이러한 추세에 따라 스포츠 재활 클리닉이나 피트니스 센터에서는 전인적 회복 프로그램의 일환으로 수분 보충을 위한 수액 주입 서비스를 제공합니다.
또한, 재생의료 및 안티에이징에 적용되어 세포 복구, 인지 기능, 장수를 지원한다고 주장하는 NAD+ 정맥 투여 요법에 대한 관심이 높아지고 있습니다. 부유층과 바이오 해커는 점적 요법을 기반으로 한 안티에이징 솔루션을 선택하는 경향이 증가하고 있으며, 이는 시장의 프리미엄 부문에 기여하고 있습니다.
정맥 내 수액 치료 시장에 영향을 미치는 과제는?
정맥 내 수액 치료의 인기가 높아지고 있음에도 불구하고, 몇 가지 문제가 시장 확대에 영향을 미치고 있습니다. 주요 관심사 중 하나는 규제 조사 및 라이선스 요건입니다. 정맥주사 요법은 의료행위로 간주되며, 많은 지역에서 면허를 소지한 의료 전문가(간호사, 의사, 구급대원)만이 합법적으로 정맥주사를 할 수 있습니다. FDA(미국), MHRA(영국), EMA(유럽)와 같은 규제 기관은 건강 관련 허위 과장 광고나 승인되지 않은 치료법을 방지하기 위해 웰니스 전문 링거 클리닉의 안전성, 효능, 마케팅 주장을 면밀히 모니터링하고 있습니다.
또 다른 중요한 과제는 정맥 투여와 잠재적 합병증에 대한 안전성 문제입니다. 정맥주사 요법은 일반적으로 올바르게 시행하면 안전하지만, 부적절한 투약, 잘못된 주입, 알레르기 반응, 감염 등이 위험할 수 있습니다. 스파나 웰니스 센터와 같은 비의료 환경에서 적절한 스크리닝 프로토콜을 거치지 않고 정맥 내 수액 공급을 받으려는 소비자는 합병증 위험이 높아질 수 있습니다.
정맥 내 수분 보충 요법에 드는 비용도 제한적인 요인으로 작용합니다. 웰니스 전문 링거는 보통 건강 보험이 적용되지 않기 때문에 주로 고소득층이 이용할 수 있는 사치스러운 서비스입니다. 가격은 성분과 투여 부위에 따라 1회당 100달러에서 500달러까지 다양하며, 대중이 부담할 수 있는 가격에는 한계가 있습니다.
또 다른 문제는 건강 증진을 목적으로 한 정맥 내 수분 보충 요법의 장기적인 효과를 뒷받침하는 표준적인 임상적 근거가 없어 회의적인 시각이 존재한다는 점입니다. 병원에서는 급성 탈수, 화학요법 지원, 영양 부족에 대한 수액 치료을 시행하고 있지만, 에너지 보충, 해독, 면역력 강화에 대한 수액 치료의 효과에 대해서는 아직 논란의 여지가 있습니다. 의료계에서는 수액 주입을 통한 수분 보충 요법이 경구 수분 및 영양 보충보다 더 나은 효과를 가져오는지 여부에 대한 논의가 계속되고 있습니다.
정맥주사요법 시장의 성장을 가속하는 요인은 무엇인가?
정맥주사 시장의 성장은 예방적 건강관리의 부상, 신속한 수분 보충 솔루션에 대한 수요 증가, 대체 웰니스 치료에 대한 소비자의 관심 증가 등 여러 요인에 기인합니다. 주요 촉진요인 중 하나는 웰빙 및 안티에이징 산업의 확대, 유명인 추천, 인플루언서 마케팅, 소셜 미디어 트렌드 등이 즉각적인 건강 및 미용 솔루션으로서 정맥 내 요법에 대한 소비자의 호기심을 자극하고 있다는 점입니다.
탈수 관련 질환 증가도 성장 요인 중 하나입니다. 열사병, 만성 편두통, 위장 장애, 운동으로 인한 탈수 등의 증상으로 인해 외래 환자 및 웰니스 환경에서의 수액 치료에 대한 수요가 증가하고 있습니다. 고령자, 잦은 여행자, 만성 질환 환자도 전해질 균형을 유지하기 위한 지지 요법으로 정맥 내 수분 공급의 혜택을 누릴 수 있습니다.
컨시어지 의료와 프리미엄 헬스케어 서비스 도입이 증가하고 있는 것도 큰 요인입니다. 많은 부유층은 집에서 링거 요법, 프라이빗 웰니스 센터, 호화로운 휴양지 등 온디맨드 개별 의료 서비스를 선호합니다. 이 때문에 고급 건강 관리의 일환으로 VIP 웰니스 링거 요법을 제공하는 컨시어지 링거 요법 제공업체가 등장하고 있습니다.
정맥주사 제제의 발전도 시장 확대에 기여하고 있습니다. 영양 칵테일 링거, 안티에이징 링거, 면역 강화 링거의 도입으로 소비자들은 보다 폭넓은 전문 링거 치료를 선택할 수 있게 되었습니다. 개개인의 건강 니즈에 맞는 미량 영양소를 풍부하게 함유한 드립 블렌드 개발로 더 많은 보급이 예상됩니다.
또한, 기업의 웰니스 프로그램이나 직장 내 건강 증진 노력은 직원들의 피로, 탈진, 탈수로 인한 생산성 저하와 싸우기 위해 수액 보충 요법을 도입하는 경우가 늘고 있습니다. 일부 기업에서는 직원 복리후생의 일환으로 현장 수분 보충 세션을 제공하고 있어 시장의 저변이 더욱 확대되고 있습니다.
정맥주사 제제의 기술 혁신, 신속한 웰니스 솔루션에 대한 수요 증가, 수명 연장 및 성능 최적화에 대한 소비자의 관심 증가로 인해 정맥주사 시장은 의료 및 비의료 분야 모두에서 꾸준한 성장이 예상됩니다. 안전, 규제 준수, 과학적 검증을 우선시하는 기업은 진화하는 헬스케어 및 웰니스 환경에서 경쟁 우위를 점할 수 있을 것으로 보입니다.
부문
서비스(면역 부스터, 에너지 부스터, 스킨케어, 편두통, 기타);성분(약용, 비약용);최종 사용(병원 및 클리닉, 웰니스 센터 및 스파, 홈 헬스케어, 기타)
조사 대상 기업 예
Baxter International
Fresenius Kabi
B. Braun Melsungen AG
ICU Medical
Grifols
Vifor Pharma
JW Life Science
Amanta Healthcare
Mobile IV Medics
Hydration Room
REVIV
Hydrate IV Bar
Prime IV Hydration
Restore Hyper Wellness
The Hydration Room
IV Therapy of Houston
IV League
IV Doc
IV Nutrition
AI 통합
Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global Intravenous (IV) Hydration Therapy Market to Reach US$3.9 Billion by 2030
The global market for Intravenous (IV) Hydration Therapy estimated at US$2.6 Billion in the year 2024, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Immune Boosters, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Energy Boosters segment is estimated at 4.5% CAGR over the analysis period.
The U.S. Market is Estimated at US$714.9 Million While China is Forecast to Grow at 10.8% CAGR
The Intravenous (IV) Hydration Therapy market in the U.S. is estimated at US$714.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$817.1 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
Why Is IV Hydration Therapy Gaining Popularity Across Healthcare and Wellness Industries?
The intravenous (IV) hydration therapy market has seen significant growth due to rising consumer awareness about rapid rehydration, wellness optimization, and medical treatments requiring intravenous nutrient infusion. IV hydration therapy is used in clinical settings, sports recovery, aesthetic medicine, and wellness centers, providing essential fluids, electrolytes, vitamins, and medications directly into the bloodstream for immediate absorption and effectiveness.
Initially used in hospitals and emergency rooms for severe dehydration, malnutrition, and chronic illnesses, IV hydration therapy has now expanded into wellness clinics, spas, and mobile IV services, catering to consumers seeking hangover relief, immune system boosts, anti-aging solutions, athletic recovery, and general well-being. The rise of biohacking culture, celebrity endorsements, and social media promotion has fueled the demand for customized IV hydration drips tailored to individual health goals.
With advancements in IV formulations, portable infusion devices, and on-demand hydration services, the IV hydration therapy market is expected to continue expanding, especially as consumers prioritize preventive healthcare, personalized wellness solutions, and non-invasive treatments for fatigue, jet lag, migraines, and immune support.
What Are the Key Trends Driving the IV Hydration Therapy Market?
One of the biggest trends in IV hydration therapy is the expansion of mobile and home-based IV infusion services. Consumers are increasingly seeking convenient, at-home IV treatments administered by licensed professionals, allowing them to avoid hospital visits and receive hydration therapy in a comfortable setting. This trend is particularly strong in urban centers, corporate wellness programs, and concierge medicine services.
Another major trend is the rise of personalized IV formulations. Instead of one-size-fits-all hydration therapy, clinics now offer customized IV drips containing vitamins, minerals, antioxidants, amino acids, and medications tailored to specific needs. The integration of AI-powered health assessments and digital health platforms is another trend shaping the market. IV hydration clinics and mobile providers are leveraging AI-driven diagnostics, telehealth consultations, and wearable technology to analyze hydration levels, vitamin deficiencies, and metabolic health, ensuring patients receive optimal IV therapy recommendations.
The expansion of IV therapy into fitness and athletic recovery is also driving demand. Many athletes, gym-goers, and weekend warriors are turning to IV hydration drips infused with amino acids, electrolytes, and performance-enhancing nutrients to aid in muscle recovery, endurance, and post-workout rehydration. This trend has led to sports rehabilitation clinics and fitness centers offering IV hydration services as part of holistic recovery programs.
Additionally, regenerative medicine and anti-aging applications are fueling interest in NAD+ IV therapy, which claims to support cellular repair, cognitive function, and longevity. High-net-worth individuals and biohackers are increasingly opting for IV-based anti-aging solutions, contributing to the premium segment of the market.
What Challenges Are Impacting the IV Hydration Therapy Market?
Despite the growing popularity of IV hydration therapy, several challenges impact its market expansion. One of the primary concerns is regulatory scrutiny and licensing requirements. IV hydration therapy is considered a medical treatment, and in many regions, only licensed healthcare professionals (nurses, doctors, paramedics) can legally administer IV infusions. Regulatory bodies such as the FDA (U.S.), MHRA (UK), and EMA (Europe) are closely monitoring the safety, efficacy, and marketing claims of wellness-focused IV clinics to prevent misleading health claims and unapproved treatments.
Another significant challenge is safety concerns related to IV administration and potential complications. While IV therapy is generally safe when administered correctly, improper dosing, incorrect IV insertion, allergic reactions, and infections can pose risks. Consumers seeking IV hydration in non-medical settings, such as spas or wellness centers, without proper screening protocols may face higher risks of complications.
The cost of IV hydration therapy is also a limiting factor. Wellness-focused IV treatments are not typically covered by health insurance, making them a luxury service accessible primarily to high-income individuals. Prices can range from $100 to $500 per session, depending on the ingredients and administration location, which limits mass-market affordability.
Another challenge is skepticism and lack of standardized clinical evidence supporting the long-term benefits of IV hydration therapy for wellness purposes. While hospitals use IV therapy for acute dehydration, chemotherapy support, and nutrient deficiencies, the effectiveness of IV drips for energy boosts, detoxification, and immune enhancement remains controversial. The medical community continues to debate whether IV hydration therapy provides superior benefits over oral hydration and nutrition.
What Factors Are Driving the Growth of the IV Hydration Therapy Market?
The growth in the IV hydration therapy market is driven by several factors, including the rise of preventive healthcare, increasing demand for rapid hydration solutions, and growing consumer interest in alternative wellness treatments. One of the key drivers is the expanding wellness and anti-aging industry, where celebrity endorsements, influencer marketing, and social media trends have fueled consumer curiosity about IV therapy as a fast-acting health and beauty solution.
The rising prevalence of dehydration-related conditions is another growth factor. Conditions such as heat exhaustion, chronic migraines, gastrointestinal disorders, and athletic dehydration have increased the demand for IV fluid therapy in outpatient and wellness settings. Elderly populations, frequent travelers, and individuals with chronic illnesses also benefit from IV hydration as a supportive therapy for maintaining electrolyte balance.
Another major driver is the increasing adoption of concierge medicine and premium healthcare services. Many high-net-worth individuals prefer on-demand, personalized medical services, including IV therapy at home, private wellness centers, and luxury retreats. This has led to the rise of concierge IV therapy providers offering VIP wellness infusions as part of an exclusive healthcare experience.
The advancement in IV therapy formulations has also contributed to market expansion. With the introduction of IV nutrient cocktails, anti-aging infusions, and immune-boosting drips, consumers now have a wider range of specialized IV treatments to choose from. The development of micronutrient-rich IV blends tailored to individual health needs is expected to drive further adoption.
Additionally, corporate wellness programs and workplace health initiatives are increasingly incorporating IV hydration therapy to help employees combat fatigue, burnout, and dehydration-related productivity loss. Some companies are offering on-site IV hydration sessions as part of their employee wellness benefits, further broadening market reach.
With ongoing innovations in IV formulations, growing demand for rapid wellness solutions, and increasing consumer interest in longevity and performance optimization, the IV hydration therapy market is expected to experience steady growth in both medical and non-medical segments. Companies that prioritize safety, regulatory compliance, and scientific validation will gain a competitive edge in this evolving healthcare and wellness landscape.
SCOPE OF STUDY:
The report analyzes the Intravenous (IV) Hydration Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Service (Immune Boosters, Energy Boosters, Skin Care, Migraine, Others); Component (Medicated, Non-medicated); End-Use (Hospitals & Clinics, Wellness Centers & Spas, Home Healthcare, Others)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 42 Featured) -
Baxter International
Fresenius Kabi
B. Braun Melsungen AG
ICU Medical
Grifols
Vifor Pharma
JW Life Science
Amanta Healthcare
Mobile IV Medics
Hydration Room
REVIV
Hydrate IV Bar
Prime IV Hydration
Restore Hyper Wellness
The Hydration Room
IV Therapy of Houston
IV League
IV Doc
IV Nutrition
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Intravenous (IV) Hydration Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Popularity of Preventive Wellness and Lifestyle Medicine Drives Demand for IV Hydration Therapy
Rising Incidence of Dehydration-Linked Conditions Among Elderly and Chronic Patients Expands Use Cases
Expansion of Mobile and On-Demand IV Therapy Services Enhances Market Accessibility
Surge in Health-Conscious Consumer Segments Spurs Growth in Vitamin-Infused IV Treatments
Increased Adoption of IV Therapy in Sports Recovery and Performance Optimization Boosts Demand
Rise in Beauty and Aesthetic Clinics Offering IV Drips Strengthens Wellness Market Penetration
Digital Booking Platforms and Telehealth Integration Enhance Consumer Engagement and Reach
Expansion of IV Therapy Franchises and Retail Clinics Supports Market Formalization
Growing Awareness of Immunity-Boosting and Anti-Aging Drips Fuels Market Interest
Shift Toward Personalized and Condition-Specific IV Cocktails Enhances Patient Satisfaction
Increased Hospital Use of IV Therapy in Emergency and Postoperative Care Sustains Core Medical Demand
Regulatory Clarity Around Clinical Safety and Medical Oversight Enhances Market Trust
Emergence of IV Hydration Subscriptions and Loyalty Programs Drives Repeat Use and Brand Retention
High Uptake of Hangover and Jetlag Recovery Drips Among Urban Millennials Expands Use in Leisure Segments
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Intravenous (IV) Hydration Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Intravenous (IV) Hydration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Intravenous (IV) Hydration Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Immune Boosters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Immune Boosters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Immune Boosters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Energy Boosters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Energy Boosters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Energy Boosters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Skin Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Skin Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Skin Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Migraine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Migraine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Other Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Home Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Home Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Wellness Centers & Spas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Wellness Centers & Spas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Wellness Centers & Spas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Medicated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Medicated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Medicated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Non-medicated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Non-medicated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Non-medicated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: USA Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: USA 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 42: USA Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: USA 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: USA Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: USA 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: Canada 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: Canada 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: Canada 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
JAPAN
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Japan 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Japan 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Japan 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
CHINA
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 65: China Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: China Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: China 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: China Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: China 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: China Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: China 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
EUROPE
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 74: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Intravenous (IV) Hydration Therapy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
FRANCE
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: France Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: France 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: France Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: France 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: France Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: France 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
GERMANY
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 95: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: Germany 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: Germany 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: Germany 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Italy 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Italy 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Italy 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
UNITED KINGDOM
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 113: UK Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: UK Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: UK 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: UK Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: UK 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: UK Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: UK 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
SPAIN
TABLE 122: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: Spain Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: Spain 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 125: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: Spain Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: Spain 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 128: Spain Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: Spain Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: Spain 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
RUSSIA
TABLE 131: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Russia Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Russia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 134: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Russia Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Russia 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 137: Russia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Russia Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Russia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Rest of Europe Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Rest of Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Rest of Europe Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Rest of Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Rest of Europe Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Rest of Europe 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 157: Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 160: Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
AUSTRALIA
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 161: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Australia Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 163: Australia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 164: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Australia Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 166: Australia 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 167: Australia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Australia Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 169: Australia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
INDIA
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 170: India Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: India Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 172: India 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 173: India Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: India Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 175: India 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 176: India Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: India Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 178: India 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 179: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: South Korea Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 181: South Korea 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 182: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: South Korea Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 184: South Korea 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 185: South Korea Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: South Korea Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 187: South Korea 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: Rest of Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: Rest of Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: Rest of Asia-Pacific Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
LATIN AMERICA
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 197: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Intravenous (IV) Hydration Therapy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 199: Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 200: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Latin America Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 202: Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 203: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: Latin America Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 205: Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 206: Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 207: Latin America Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 208: Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 209: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Argentina Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 211: Argentina 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 212: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 213: Argentina Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 214: Argentina 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 215: Argentina Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 216: Argentina Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 217: Argentina 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
BRAZIL
TABLE 218: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 219: Brazil Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 220: Brazil 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 221: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 222: Brazil Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 223: Brazil 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 224: Brazil Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 225: Brazil Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 226: Brazil 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
MEXICO
TABLE 227: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 228: Mexico Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 229: Mexico 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 230: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 231: Mexico Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 232: Mexico 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 233: Mexico Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 234: Mexico Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 235: Mexico 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 237: Rest of Latin America Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 238: Rest of Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 240: Rest of Latin America Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 241: Rest of Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 243: Rest of Latin America Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 244: Rest of Latin America 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
MIDDLE EAST
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 245: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Intravenous (IV) Hydration Therapy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 247: Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 248: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 249: Middle East Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 250: Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 251: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 252: Middle East Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 253: Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 254: Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 255: Middle East Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 256: Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
IRAN
TABLE 257: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 258: Iran Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 259: Iran 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 260: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 261: Iran Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 262: Iran 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 263: Iran Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 264: Iran Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 265: Iran 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
ISRAEL
TABLE 266: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 267: Israel Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 268: Israel 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 269: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 270: Israel Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 271: Israel 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 272: Israel Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 273: Israel Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 274: Israel 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 276: Saudi Arabia Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 277: Saudi Arabia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 279: Saudi Arabia Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 280: Saudi Arabia 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 282: Saudi Arabia Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 283: Saudi Arabia 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 284: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 285: UAE Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 286: UAE 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 287: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 288: UAE Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 289: UAE 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 290: UAE Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 291: UAE Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 292: UAE 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 294: Rest of Middle East Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 295: Rest of Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 297: Rest of Middle East Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 298: Rest of Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 300: Rest of Middle East Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 301: Rest of Middle East 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030
AFRICA
Intravenous (IV) Hydration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 302: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 303: Africa Historic Review for Intravenous (IV) Hydration Therapy by Service - Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 304: Africa 15-Year Perspective for Intravenous (IV) Hydration Therapy by Service - Percentage Breakdown of Value Sales for Immune Boosters, Energy Boosters, Skin Care, Migraine and Other Services for the Years 2015, 2025 & 2030
TABLE 305: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 306: Africa Historic Review for Intravenous (IV) Hydration Therapy by End-Use - Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 307: Africa 15-Year Perspective for Intravenous (IV) Hydration Therapy by End-Use - Percentage Breakdown of Value Sales for Home Healthcare, Other End-Uses, Hospitals & Clinics and Wellness Centers & Spas for the Years 2015, 2025 & 2030
TABLE 308: Africa Recent Past, Current & Future Analysis for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 309: Africa Historic Review for Intravenous (IV) Hydration Therapy by Component - Medicated and Non-medicated Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 310: Africa 15-Year Perspective for Intravenous (IV) Hydration Therapy by Component - Percentage Breakdown of Value Sales for Medicated and Non-medicated for the Years 2015, 2025 & 2030